Latest News

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

MD Anderson Cancer Center, AAAS Fellows

Six Researchers From MD Anderson Elected as AAAS Fellows

In recognition of their contributions to basic, translational, and clinical research, six faculty members from The University of Texas MD Anderson Cancer Center have been named Fellows of the American Association for the Advancement of Science (AAAS).

Medicine

Channels:

Colon Cancer, Colectomy, Colon Surgery, Chemotherapy, NCCN, NCCN Guidelines in Oncology, MD Anderson Cancer Center, health services research

Quality of Care for Older Texas Patients with Colon Cancer on the Rise, Still Room for Improvement

132386_Zhao_H.jpg

Research from The University of Texas MD Anderson Cancer Center finds adherence to surgical treatment guidelines has improved significantly among older Texas patients with colon cancer since 2001, while adherence to chemotherapy guidelines has remained largely unchanged. The study, published today in Cancer, identifies factors influencing adherence rates, including socioeconomic status and access to skilled physicians.

Medicine

Channels:

Moon Shots Program, MD Anderson Cancer Center, Lung Cancer, EGFR inhibitor, Beta Blockers, NSCLC Patients

Chronic Stress Hormones May Promote Resistance to EGFR Inhibitors in Lung Cancer Patients

Heymach_J_01.jpg

Elevated levels of chronic stress hormones, such as those produced by psychological distress, may promote resistance to drugs commonly used to treat lung cancer patients with EGFR mutations, according to new research from The University of Texas MD Anderson Cancer Center. Retrospective analysis of clinical patient data suggests that beta blocker drugs may slow or prevent the development of resistance to EGFR inhibitors.

Medicine

Channels:

MD Anderson Cancer Center, Melanoma, liquid biopsy

Circulating Tumor Cells Associated with Relapse in Late-Stage Melanoma Patients

Lucci.jpg

A study revealing a connection between circulating tumor cells (CTCs) and relapse in stage IV melanoma patients points to liquid biopsy as a potential predictor of patients at high risk for disease progression. CTCs, tumor cells shed into the bloodstream or lymphatic system, can lead to additional tumor growth and/or metastasis to distant sites. Findings from the study, led by Anthony Lucci, M.D., professor of Breast Surgical Oncology and Surgical Oncology at The University of Texas MD Anderson Center, will be presented at the Nov. 7 annual meeting of the Western Surgical Association.

Medicine

Channels:

Cancer, Moon Shots Program, MD Anderson Cancer Center

MD Anderson’s Moon Shots Program Celebrates Five-Year Anniversary

The University of Texas MD Anderson Cancer Center celebrates the five-year anniversary of its Moon Shots Program™, a collaborative effort to accelerate the development of scientific discoveries into clinical advances that save patients’ lives. Launched in the fall of 2012, the program already has yielded notable discoveries across the spectrum of cancer care, including prevention, early detection and treatment, and has inspired philanthropic support totaling more than $451 million.

Medicine

Channels:

Melanoma, Microbiome, microbiome and cancer treatment, Immunotherapy

Bacteria in the Gut Modulates Response to Immunotherapy in Melanoma

203533_Wargo_J.jpg

Bacteria that live in the human digestive tract can influence how cancer responds to immunotherapy, opening a new avenue for research to improve treatment, a team led by researchers at The University of Texas MD Anderson Cancer Center reports in the journal Science.

Medicine

Channels:

MD Anderson Cancer Center, dream team , Stand Up To Cancer, Pancreatic Cancer

Dream Team Aims to Intercept Pancreatic Cancer Before It Flourishes

205356_Maitra_A1.jpg

Deeply entrenched and mature by the time it’s found, pancreatic cancer is one of the hardest to defeat. A Dream Team assembled by Stand Up to Cancer and led by an investigator at The University of Texas MD Anderson Cancer Center will test new ways to find the disease in its emerging, more vulnerable phase in people who are at high risk for developing it.

Medicine

Channels:

Lung Cancer, Egfr Mutations, Targeted Therapies

Drug Yields High Response Rates for Lung Cancer Patients with Harsh Mutation

john_heymach.jpg

A targeted therapy resurrected by the Moon Shots Program™ at The University of Texas MD Anderson Cancer Center has produced unprecedented response rates among patients with metastatic non-small cell lung cancer that carries a highly treatment-resistant mutation.

Medicine

Channels:

MD Anderson Cancer Center, National Academy of Medicine, Breast Cancer

V. Craig Jordan, Ph.D., elected to the National Academy of Medicine

215692_Jordan_C.jpg

V. Craig Jordan, Ph.D., professor of Breast Medical Oncology, has been elected to the National Academy of Medicine for his discovery of selective estrogen receptor modulators (SERMs), a class of drugs with far-reaching impact on women’s health.

Medicine

Channels:

MD Anderson Cancer Center, Immunotherapy, Partnership for accelerating cancer therapies, NIH, Cancer Moonshot, Moon Shots Program

MD Anderson Team Selected for National Push to Expand Immunotherapy

143953_Wistuba_I11.jpg

A major national effort to expand the reach of cancer immunotherapy to benefit more patients will draw upon the expertise of a team of researchers at The University of Texas MD Anderson Cancer Center.







Chat now!